NDC00270-0265-20 — IODIPAMIDE MEGLUMINE INJECTION

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC00270-0265-20: IODIPAMIDE MEGLUMINE INJECTION.

The IODIPAMIDE MEGLUMINE INJECTION is a the manufacturer industrial component. Key specifications include special_features: ACTIVE MEDICAMENT MEDICINAL STRENGTH: 52.000 PERCENTAGE, W/V MEGLUMINE IODIPAMIDE ACTIVE INGREDIENT, primary_container_type: VIAL, supplementary_features: D-DAY ITEM FOR DOD, protective_storage_feature: SUBJECT TO DAMAGE BY FREEZING, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA. This part is cataloged in the U.S.

Government catalog under NSN 6505-00-926-9109, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC00270-0265-20

NSN: 6505-00-926-9109
FSC: 6505 — Drugs and Biologicals
CAGE: 05HX5 — BRACCO DIAGNOSTICS INC. (USA)

SPECIFICATIONS

special_features	ACTIVE MEDICAMENT MEDICINAL STRENGTH: 52.000 PERCENTAGE, W/V MEGLUMINE IODIPAMIDE ACTIVE INGREDIENT
primary_container_type	VIAL
supplementary_features	D-DAY ITEM FOR DOD
protective_storage_feature	SUBJECT TO DAMAGE BY FREEZING
pharmaceutical_vehicle_type	AQUEOUS
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
primary_container_content_quantity	20.000 MILLILITERS
part_name_assigned_by_controlling_agency	IODIPAMIDE MEGLUMINE INJECTION USP 52% 20ML
NSN	6505-00-926-9109

COMPONENT DIAGRAM

KEY FEATURES

•

PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS

•

SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

PRIMARY CONTAINER TYPE: VIAL

•

PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING

•

PHARMACEUTICAL VEHICLE TYPE: AQUEOUS

TECHNICAL CHARACTERISTICS

PRIMARY CONTAINER CONTENT QUANTITY	20.000 MILLILITERS
SUPPLEMENTARY FEATURES	D-DAY ITEM FOR DOD
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPE	VIAL
SPECIAL FEATURES	ACTIVE MEDICAMENT MEDICINAL STRENGTH: 52.000 PERCENTAGE, W/V MEGLUMINE IODIPAMIDE ACTIVE INGREDIENT
PROTECTIVE STORAGE FEATURE	SUBJECT TO DAMAGE BY FREEZING
PART NAME ASSIGNED BY CONTROLLING AGENCY	IODIPAMIDE MEGLUMINE INJECTION USP 52% 20ML
PHARMACEUTICAL VEHICLE TYPE	AQUEOUS

OTHER ITEMS IN FSC 6505 — Drugs and Biologicals

Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.

6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347

SUBSTITUTES & CROSS-REFERENCES 1

NDC00003-0265-20Reference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedAcquisition advice: Terminal item — stock exhausted; no further procurementNo demilitarization required

Ready to buy NDC00270-0265-20?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC00270-0265-20?

NDC00270-0265-20 is a IODIPAMIDE MEGLUMINE INJECTION.

What parts can replace NDC00270-0265-20?

There is 1 known substitute for NDC00270-0265-20: NDC00003-0265-20. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC00270-0265-20?

NDC00270-0265-20 is cataloged in the U.S. Government catalog under NSN 6505-00-926-9109. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC00270-0265-20 — IODIPAMIDE MEGLUMINE INJECTION

Request a Quote — NDC00270-0265-20